Oxford Nanopore at AACR 2025
The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting showcases cutting-edge cancer science and medicine.
Oxford Nanopore will have a booth in the exhibit hall, and will host an Exhibitor Spotlight Theater Monday, April 28th, 2025. Session details to come soon!
Spotlight Theater speakers
)
Oxford Nanopore introduction
Claire Attwooll, Senior Director, Clinical Solutions, Oxford Nanopore Technologies
...
)
Prognostic importance of direct assignment of parent-of-origin via long-read genome and epigenome sequencing in retinoblastoma
Debarshi Mustafi, Principal Investigator, University of Washington
Debarshi grew up in Chicago and earned his bachelor’s degree with Honors in Chemistry from the Unive...
)
Rapid epigenomic classification of acute leukemia
Gabriel Griffin, Assistant Professor, Dana-Farber Cancer Institute
Dr. Griffin is Assistant Professor of Pathology at Harvard Medical School, Principal Investigator in...